Glucose #MinimalModels news from #ATTD2026 reports the launch of the first physician-ready software for the oral minimal model analysis in seconds (#AOMM) - get in touch to test the beta version for free in your center! #AOMM has been validated >+10k tests
Glucose #MinimalModels news from #ATTD2026 reports the launch of the first physician-ready software for the oral minimal model analysis in seconds (#AOMM) - get in touch to test the beta version for free in your center! #AOMM has been validated >+10k tests
Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP) - Journal of Pharmaceutical Sciences https://t.co/ezhWlNKZz4
New article alert on #longacting drug classification spanning from small molecules like #lenacapavir to proteins like #glp1 - a classification like #bcs. Free access below.
https://t.co/SRgO9WUzfN
26-28 November 2025 University of Warwick:
"Simone Perazzolo is presenting at the renowned UKPK workshop on the topic of using modeling to scale from animals to human": https://t.co/rWHUVOoSqz
Just back from the #UKPK workshop at @UniofWarwick ��� fantastic talks on PK/PD modeling of emerging drug classes (long-acting injectables, PROTACs, radioligands, and more). There was an appearance of Prof K Godfrey!
#Throwback to the 1st International Workshop on Long-Acting Anti-Infectives (LAAI) 2025, held on 21–22 May in New Orleans, where we dove into how #LongActing formulations are reshaping approaches to treatment and prevention.
📽️ Videos and slides: https://t.co/pv509e0c1s
#LAAIWS